HiFiBiO SAS to present advances in functional therapeutic antibody discovery at The European Antibody Congress on Tuesday, November 15, 2016

CAMBRIDGE, MA, AND PARIS, FRANCE, November 11, 2016 – HiFiBiO SAS today announced that the latest results from their CelliGO™ platform will be presented by Senior Scientist and Project Leader Dr. Annabelle Gerard as part of the 2016 European Antibody Conference taking place in Basel, Switzerland. The presentations will feature the latest achievements in deep mining human and rodent immune repertoires for therapeutic antibody discovery and deep mining approaches to addressing challenging targets such as cell surface targets using in-droplet functional assays.

Presentation Title: Next-generation therapeutic antibodies by functional screening in droplets: Single-cell droplet based microfluidic technology. The presentation, will be on Tuesday, Nov. 15 at 9:35 CET.